NCT00561379View on ClinicalTrials.gov

Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab

NACompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Lymphoma, Large-Cell, Diffuse
Interventions
DRUG

CHOP+RITUXIMAB

CHOP-14- Rituximab x 8 courses

DRUG

CEEP-RITUXIMAB

High dose chemotherapy with rituximab including autologous stem cell support.

Trial Locations (1)

Unknown

Nantes University Hospital, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT00561379 - Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab | Biotech Hunter | Biotech Hunter